Derma Sciences, Inc. (DSCI)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Stephen T. Wills
Employees:
260
214 CARNEGIE CENTER, SUITE 300, PRINCETON, NJ 08540
6095144744

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Derma Sciences, Inc. operates as a medical device company in the wound care market. Its Advanced Wound Care segment offers MEDIHONEY dressings for managing non-chronic and hard-to-heal wounds, including chronic ulcers, burns, and post-operative wo...

Data derived from most recent annual or quarterly report
Market Cap 197.885 Million Shares Outstanding28.269 Million Avg 30-day Volume 99.4 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 0.0 / Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from DSCI instead.

View recent insider trading info

Funds Holding DSCI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding DSCI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MOUSSA ROBERT G

  • Director
No longer subject to file 2017-02-24 0

CONJEEVARAM SRINI

  • Director
No longer subject to file 2017-02-24 0

WILLS STEPHEN T

  • Director
  • EXECUTIVE CHAIRMAN
No longer subject to file 2017-02-24 0

COLE ROBERT C SEE REMARKS

  • Officer
No longer subject to file 2017-02-24 0

YETTER JOHN E EVP, FINANCE & CFO

  • Officer
No longer subject to file 2017-02-24 0

NAVARRO SAMUEL E

  • Director
No longer subject to file 2017-02-24 0

EIGNER FREDERIC EXECUTIVE VP - OPERATIONS

  • Officer
No longer subject to file 2017-02-24 0

HEWLETT BRETT

  • Director
No longer subject to file 2017-02-24 0

WOLFENSON BARRY

  • SEE REMARKS
No longer subject to file 2016-07-31 0

WESSON BRUCE F

  • FORMER DIRECTOR
0 2016-05-31 0

PAUL AMY S

  • FORMER DIRECTOR
0 2016-05-31 0

QUILTY EDWARD J FORMER PRESIDENT & CEO

  • Officer
192,396 2015-12-20 0

STAFFORD C RICHARD

  • FORMER DIRECTOR
0 2015-05-27 0

CAMINIS JOHN CHIEF MEDICAL OFFICER

  • Officer
0 2015-03-09 0

RA CAPITAL MANAGEMENT, LLC

KOLCHINSKY PETER

RA CAPITAL HEALTHCARE FUND LP

  • FMR 10% OWNER - SEE FN (1)-(5)FMR 10% OWNER - SEE FN (1)-(5)FMR 10% OWNER - SEE FN (1)-(5)
No longer subject to file 2014-01-10 0

MARTIN WILLIAM C

RAGING CAPITAL MANAGEMENT, LLC

RAGING CAPITAL MASTER FUND, LTD.

  • 10% Owner
No longer subject to file 2013-05-28 0

GILBERT PAUL M

  • Director
  • SEE REMARKS
15,000 2013-05-23 0

OBRIEN JAMES T

  • FORMER DIRECTOR
No longer subject to file 2013-03-29 0

MARTIN WILLIAM C

RAGING CAPITAL MANAGEMENT, LLC

RAGING CAPITAL FUND, LP

RAGING CAPITAL FUND (QP), LP

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
0 2013-01-01 0

RAGING CAPITAL MASTER FUND, LTD.

  • 10% Owner
1,332,557 2013-01-01 0

KEIM RICHARD

  • FORMER DIRECTOR
No longer subject to file 2012-05-30 0

LEHMAN BROTHERS HOLDINGS INC

  • 10% Owner
803,570 2012-02-06 0

COMVITA LTD

  • 10% Owner
864,880 2011-04-29 0

COMVITA NEW ZEALAND LTD

  • 10% Owner
No longer subject to file 2010-03-31 0

RIVEST DANIEL EXEC. VP - FIRST AID PRODUCTS

  • Officer
0 2009-03-31 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments